Finance

Lists
Why is 301408 down 7.75%?
Dive Deeper
301408:SHE
Anhui Huaren Health Pharmaceuticl Co Ltd
CN¥14.28
-7.75%
(-1.20) 1D
Oct 14, 3:04:28 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301408...
Open
CN¥15.00
High
CN¥15.00
Low
CN¥14.27
Mkt. cap
6.19B
Avg. vol.
11.70M
Volume
23.42M
Dividend
0.70%
Quarterly dividend
CN¥0.03
Ex-dividend date
May 27, 2026
P/E ratio
25.56
52-wk high
CN¥29.76
52-wk low
CN¥12.55
EPS
CN¥0.56
Shares outstanding
400.01M
No. of employees
9K
Open
CN¥15.00
High
CN¥15.00
Low
CN¥14.27
Mkt. cap
6.19B
Avg. vol.
11.70M
Volume
23.42M
Dividend
0.70%
Quarterly dividend
CN¥0.03
Ex-dividend date
May 27, 2026
P/E ratio
25.56
52-wk high
CN¥29.76
52-wk low
CN¥12.55
EPS
CN¥0.56
Shares outstanding
400.01M
No. of employees
9K
News stories
From web sources and news partners
About Anhui Huaren Health Pharmaceuticl Co Ltd
CEO-
Employees8.94K
FoundedJun 29, 2001
Headquarters-
SectorDrug
Websitehrjkjt.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.39B
1.59B
1.42B
1.40B
Cost of goods sold
920.83M
1.04B
921.66M
929.72M
Cost of revenue
920.83M
1.04B
921.66M
929.72M
Research and development expenses
9.69M
7.03M
9.56M
7.16M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
359.24M
396.06M
360.23M
372.07M
Operating expense
372.83M
419.52M
376.51M
390.24M
Total operating expenses
1.29B
1.46B
1.30B
1.32B
Operating income
94.90M
135.33M
122.81M
83.74M
Other non operating income
-8.66M
6.60M
-5.04M
1.44M
EBT including unusual items
74.84M
72.04M
110.79M
89.51M
EBT excluding unusual items
88.92M
127.41M
115.92M
76.72M
Income tax expense
15.13M
29.57M
24.71M
27.19M
Effective tax rate
20.22%
41.04%
22.30%
30.38%
Other operating expenses
1.12M
8.89M
4.42M
11.45M
Net income
52.98M
34.63M
79.34M
56.57M
Net profit margin
3.82%
2.17%
5.58%
4.03%
Earnings per share
-
-
-
-
Interest and investment income
2.65M
5.74M
2.32M
3.49M
Interest expense
-
-20.14M
-4.17M
-11.65M
Net interest expenses
2.65M
-14.40M
-1.86M
-8.16M
Depreciation and amortization charges
-
-
-
-
EBITDA
104.62M
146.42M
133.90M
95.44M
Gain or loss from assets sale
1.99M
-3.74M
-
-1.58M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps